The analysis, interpretation, and presentation of quality of life data.

作者: Richard Stephens

DOI: 10.1081/BIP-120028506

关键词:

摘要: Abstract All too often in clinical trials the assessment of quality life is seen as a bolt-on study. Consequently insufficient consideration given to its design, collection, analysis and presentation, impact on trial results practice minimal. In many key endpoint, it vital that expertise involved soon possible design. Setting priori hypotheses will focus decisions regarding which questionnaire use, when administer it, sample size required, primary analyses. Nevertheless data are complex, require much skill determining how deal with multi-dimensional longitudinal data, missing. There no agreed standard ways analysing presenting but there guidelines, if followed, add transparency way have been calculated. Understanding treatments on...

参考文章(29)
D Osoba, G Rodrigues, J Myles, B Zee, J Pater, Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology. ,vol. 16, pp. 139- 144 ,(1998) , 10.1200/JCO.1998.16.1.139
NM Bleehen, , DJ Girling, P Hopwood, G Lallemand, D Machin, RJ Stephens, AJ Bailey, Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis British Journal of Cancer. ,vol. 73, pp. 406- 413 ,(1996) , 10.1038/BJC.1996.71
Robert M. Kaplan, Quality of life assessment for cost/utility studies in cancer Cancer Treatment Reviews. ,vol. 19, pp. 85- 96 ,(1993) , 10.1016/0305-7372(93)90061-U
David Waller, David J. Fairlamb, Nicole Gower, Robert Milroy, Michael D. Peake, Robin M. Rudd, Stephen G. Spiro, Richard J. Stephens, O-179 The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the surgical setting Lung Cancer. ,vol. 41, ,(2003) , 10.1016/S0169-5002(03)91837-X
F MACBETH, J BOLGER, P HOPWOOD, N BLEEHEN, J CARTMELL, D GIRLING, D MACHIN, R STEPHENS, A BAILEY, Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status Clinical Oncology. ,vol. 8, pp. 167- 175 ,(1996) , 10.1016/S0936-6555(96)80041-0
D Curran, N Aaronson, B Standaert, G Molenberghs, P Therasse, A Ramirez, M Koopmanschap, H Erder, M Piccart, Summary measures and statistics in the analysis of quality of life data: an example from an EORTC–NCIC–SAKK locally advanced breast cancer study European Journal of Cancer. ,vol. 36, pp. 834- 844 ,(2000) , 10.1016/S0959-8049(00)00056-3
Michele Saunders, Stanley Dische, Ann Barrett, Angela Harvey, Della Gibson, Mahesh Parmar, Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial The Lancet. ,vol. 350, pp. 161- 165 ,(1997) , 10.1016/S0140-6736(97)06305-8
M. T King, The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 Quality of Life Research. ,vol. 5, pp. 555- 567 ,(1996) , 10.1007/BF00439229